Chemed (CHE) Depreciation & Amortization (CF) (2009 - 2026)

Chemed has reported Depreciation & Amortization (CF) for 18 years, with the latest figure at $16.9 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 5.34% year-over-year to $16.9 million; the trailing twelve-month figure through Mar 2026 stood at $65.7 million (up 3.86% YoY), and the FY2025 full-year result was $64.8 million, up 2.84% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $16.9 million, up from $16.3 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $16.9 million in Q1 2026, with the low at $14.6 million in Q4 2022.
• Average Depreciation & Amortization (CF) over 5 years is $15.6 million, with a median of $15.7 million recorded in 2024.
• Year-over-year, Depreciation & Amortization (CF) decreased 5.51% in 2022 and climbed 6.82% in 2024.
• Tracing CHE's Depreciation & Amortization (CF) over 5 years: stood at $14.6 million in 2022, then grew by 6.37% to $15.5 million in 2023, then rose by 1.88% to $15.8 million in 2024, then advanced by 3.15% to $16.3 million in 2025, then advanced by 3.33% to $16.9 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $16.9 million (Q1 2026), $16.3 million (Q4 2025), and $16.2 million (Q3 2025), per Business Quant data.

Peer Comparison